Work

Daratumumab, Lenalidomide, and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Year: 2023

Type: article

Source: The Hematologist

DOI: 10.1182/hem.v20.2.202329

Authors: Carlyn Tan, Saad Z. Usmani

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4320925653

FWCI: 0.532

Cites: 10

Cited by: 3

Related to: 10